Skip to Main Content

Rise and shine, everyone, another busy day is on the way. And this will be an especially busy one for us as we engage in a round of chats with a multitude of interesting folks. A break from the usual routine, in some ways. Nonetheless, we continue to forage for interesting items, despite the oppressive heat. So time to stay cool with another hot cup of stimulation, yes? As always, please feel free to join us. Meanwhile, here is a new batch of tidbits to help you along. Hope all goes well today and do stay in touch. …

“Little to no progress” has been made in achieving gender representation in the pharmaceutical industry, Pharmafile writes, citing a new report. Female representation on executive committees tripled to 26%, up from 8% in 2018, but representation in roles with profit and loss responsibility had halved over the same period to 4%, and representation of female executive directors on boards fell to 6% from 10%. Given these rates of change, the report estimated that it would take until 2090 before gender parity was reached in the industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!